香港股市 已收市

Thermo Fisher Scientific Inc. (TMO)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
572.38+1.13 (+0.20%)
收市:04:00PM EDT
572.36 -0.02 (-0.00%)
收市後: 07:50PM EDT

Thermo Fisher Scientific Inc.

168 Third Avenue
Waltham, MA 02451
United States
781 622 1000
https://www.thermofisher.com

版塊Healthcare
行業Diagnostics & Research
全職員工122,000

高階主管

名稱頭銜支付行使價出生年份
Mr. Marc N. CasperChairman, President & CEO5.08M47.09M1968
Mr. Stephen WilliamsonSenior VP & CFO2.02M10.57M1967
Mr. Michel LagardeExecutive VP & COO2.22M1975
Ms. Lisa P. BrittChief Human Resources Officer & Senior VP1.21M1968
Mr. Gianluca PettitiExecutive Vice President1.66M911.34k1979
Mr. Joseph R. HolmesVP & Chief Accounting Officer1980
Mr. Ryan J. SnyderSenior VP & Chief Information Officer
Dr. Karen E. Nelson Ph.D.Chief Scientific Officer
Mr. Rafael TejadaVice President of Investor Relations
Mr. Michael A. Boxer Esq.Senior VP & General Counsel1.76M2.9M1962
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

公司管治

截至 2024年5月1日 止,Thermo Fisher Scientific Inc. 的 ISS 管治質素評分為 2。 Pillar 分數正在審核中:5;董事會:7;股東權利:1;現金賠償:3。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。